Repinotan Hydrochloride

盐酸瑞匹诺坦

Report date: 2025/06/10 15:05:04
NME

Base Information

Drug NameRepinotan Hydrochloride
Drug Alias Name瑞匹诺坦盐酸盐repinotanumBay-x-3702BAYX-3702X-3702 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsIschemic StrokeStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[15] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsIschemic StrokeStroke

Other Information

ATC CodeN/A
Related LinksWikipedia